Literature DB >> 18452853

Erythropoietins should be used according to guidelines.

Matti S Aapro, Gunnar Birgegård, Carsten Bokemeyer, Paul Cornes, Jan Foubert, Pere Gascon, John Glaspy, Eva Hellström-Lindberg, Hartmut Link, Heinz Ludwig, Anders Osterborg, Lazzaro Repetto, Pierre Soubeyran.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18452853     DOI： 10.1016/S1470-2045(08)70115-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

1.  Efficacy of epoetin-beta 30,000 IU/week in correcting anaemia in patients with gastrointestinal tumours subjected to concomitant chemoradiotherapy.

Authors:  Antonio Gómez; Mercedes Salgado; Manuel Valladares-Ayerbes; Mónica Jorge; Ana Carballo; Sonia Candamio; Pilar Izquierdo; Paula Peleteiro; Rafael López
Journal:  Clin Transl Oncol       Date:  2010-12       Impact factor: 3.405

2.  Promoting evidence-based management of anemia in cancer patients: concurrent and discriminant validity of RESPOND, a web-based clinical guidance system based on the EORTC guidelines for supportive care in cancer.

Authors:  Joanna Van Erps; Matti Aapro; Karen MacDonald; Pierre Soubeyran; Matthew Turner; Hans Warrinnier; Tara Albrecht; Ivo Abraham
Journal:  Support Care Cancer       Date:  2009-11-11       Impact factor: 3.603

Review 3.  Iron in multiple myeloma.

Authors:  Kristina VanderWall; Tracy R Daniels-Wells; Manuel Penichet; Alan Lichtenstein
Journal:  Crit Rev Oncog       Date:  2013

4.  Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece.

Authors:  Eleftheria Nikolaidi; Magdalini Hatzikou; Mary Geitona
Journal:  Cost Eff Resour Alloc       Date:  2013-07-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.